CURAXIS PHARMACEUTICAL CORP Stock-Based Compensation
CURAXIS PHARMACEUTICAL CORP reported Stock-Based Compensation of $47.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-05-14
- CURAXIS PHARMACEUTICAL CORP share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $47.00K, a 2.17% increase year-over-year.
- CURAXIS PHARMACEUTICAL CORP share-based payment arrangement, noncash expense for the quarter ending 2011-12-31 was $49.00K, a 23.44% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP share-based payment arrangement, noncash expense for the quarter ending 2011-09-30 was $83.00K, a 46.10% decline year-over-year.
- CURAXIS PHARMACEUTICAL CORP share-based payment arrangement, noncash expense for the quarter ending 2011-06-30 was -$5.00K.
- CURAXIS PHARMACEUTICAL CORP share-based payment arrangement, noncash expense for fiscal 2011 was $173.00K, a 62.39% decline from fiscal 2010.
- CURAXIS PHARMACEUTICAL CORP share-based payment arrangement, noncash expense for fiscal 2010 was $460.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 41 month | Share-based Payment Arrangement, Noncash Expense 127 month | Share-based Payment Arrangement, Noncash Expense 130 month | Share-based Payment Arrangement, Noncash Expense 133 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | $47.00K 10-Q · filed 2012-05-14 | $96.00K derived: sum of 2 quarters · filed 2012-05-14 | $179.00K derived: sum of 3 quarters · filed 2012-05-14 | $174.00K derived: sum of 4 quarters · filed 2012-05-14 | $4.29M 10-Q · filed 2012-05-14 | |||
| 2011-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $132.00K derived: sum of 2 quarters · filed 2012-03-29 | $127.00K derived: sum of 3 quarters · filed 2012-03-29 | $173.00K 10-K · filed 2012-03-29 | $4.24M 10-K · filed 2012-03-29 | |||
| 2011-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $78.00K derived: sum of 2 quarters · filed 2011-11-10 | $124.00K 10-Q · filed 2011-11-10 | $188.00K derived: sum of 4 quarters · filed 2012-05-14 | $4.19M 10-Q · filed 2011-11-10 | |||
| 2011-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-12 | $41.00K 10-Q · filed 2011-08-12 | $105.00K derived: sum of 3 quarters · filed 2012-05-14 | $259.00K derived: sum of 4 quarters · filed 2012-05-14 | $4.11M 10-Q · filed 2011-08-12 | |||
| 2011-03-31 | $46.00K 10-Q · filed 2012-05-14 | $110.00K derived: sum of 2 quarters · filed 2012-05-14 | $264.00K derived: sum of 3 quarters · filed 2012-05-14 | |||||
| 2010-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $218.00K derived: sum of 2 quarters · filed 2012-03-29 | $460.00K 10-K · filed 2012-03-29 | |||||
| 2010-09-30 | $154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $396.00K 10-Q · filed 2011-11-10 | ||||||
| 2010-06-30 | $242.00K 10-Q · filed 2011-08-12 |